Pharma Focus Asia
KP - Sustainable Packaging Solutions

Genevoyager Plans for the Construction of New Gene Therapy CDMO Facility in USA

Introduction:

Genevoyager unveils state-of-the-art gene therapy contract development and manufacturing organisation (CDMO) facility in USA.

Features:

The newly inaugurated cGMP facility boasts state-of-the-art infrastructure, featuring its proprietary One-Bac 4.0 system integrated with the Sf-RVF® cell line.

The purpose-built facility covering an 68,000 square feet is designed to streamline the process of developing, manufacturing, and scaling AAV gene therapy products. 

Its design and infrastructure are tailored specifically to support the seamless progression of these therapies from concept to market, ensuring efficient production and adherence to regulatory standards throughout every stage of the process.

With the operation of this advanced facility, comprehensive development and manufacturing services will be offered for AAV, lentivirus, oncolytic viruses, and recombinant proteins. 

This diverse range of capabilities enables the provision of tailored solutions to advance innovative biologics from conception to commercialisation, serving the needs across various therapeutic areas.

Specifications:

Name    Genevoyager
Type      New Construction

Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024Gibco Adherent Kidney Media PanelAsia Healthcare Week 2024Equinix accelerated medical research...CPHI Korea 2024CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?